669
Views
8
CrossRef citations to date
0
Altmetric
Original Research Articles

Bioethical issues of preventing hereditary diseases with late onset in the Sakha Republic (Yakutia)

, , , , &
Article: 25062 | Received 29 May 2014, Accepted 02 Jul 2014, Published online: 24 Jul 2014

References

  • Holtzman NA. The UK's Policy on genetic testing services supplied direct to the public – two spheres and two tiers. Community Genet. 1998; 1: 49–52.
  • Holtzman NA. Promoting safe and effective genetic tests in the United States: work of the task force on genetic testing. Clin Chem. 1999; 45: 732–8.
  • Thomson G, Esposito MS. The genetic of complex disease. Trends Cell Biol. 1999; 9: 17–20.
  • Korf BR, Rehm HL. New approaches to molecular diagnosis. JAMA. 2013; 309: 1511–21.
  • Natrajan R, Reis-Filho JS. Next-generation sequencing applied to molecular diagnostics. Expert Rev Mol Diagn. 2011; 11: 425–44.
  • Kash KM, Ortega-Verdejo K, Dabney MK, Holland JC, Miller DG, Osborne MP. Psychological aspects of cancer genetics: women at risk for breast and ovarian cancer. Semin Surg Oncol. 2000; 18: 333–8.
  • van Maarle MC, Stouthard ME, Marang-van de Mheen PJ, Klazinga NS, Bonsel GJ. How disturbing is it to be approached for a genetic cascade screening programme for familial hypercholesterolaemia?. Community Genet. 2001; 4: 244–52.
  • Bellcross CA, Page PZ, Meaney-Delman D. Direct-to-consumer personal genome testing and cancer risk prediction. Cancer J. 2012; 18: 293–302.
  • Billings P, Kohn M, de Cuevas M, Beckwith J, Alper JS, Natowicz MR. Discrimination as a consequence of genetic screening. Am J Hum Genet. 1992; 50: 476–82.
  • Nedelcu R, Blazer K, Schwerin B, Gambol P, Mantha P, Uman G, etal. Genetic discrimination: the clinician perspective. Clin Genet. 2004; 66: 311–17.
  • Su B, Macer D. Privacy versus public interest in developing human genetic databases. Eubios J Asian Int Bioeth. 2004; 14: 82–4.
  • Wroe AL, Salkovskis PM, Rimes KA. The prospect of predictive testing for personal risk: attitudes and decision making. Behav Res Ther. 1998; 36: 599–619.
  • Taylor SD. Predictive genetic test decisions for Huntington's disease: context, appraisal and new moral imperatives. Soc Sci Med. 2004; 58: 137–49.
  • Smith CO, Lipe HP, Bird TD. Impact of presymptomatic genetic testing for hereditary ataxia and neuromuscular disorders. Arch Neurol. 2004; 61: 875–80.
  • Klitzman R. Views of discrimination among individuals confronting genetic disease. J Genet Couns. 2010; 19: 68–83.
  • Fletcher JC, Berg K, Tranoy KE. Ethical aspects of medical genetics. A proposal for guidelines in genetic counseling, prenatal diagnosis and screening. Clin Genet. 1985; 27: 199–205.
  • Kolker A, Burke BM, Phillips JU. Attitudes about abortion of women who undergo prenatal diagnosis. Res Sociol Health Care. 1991; 9: 49–73.
  • Kowalcek I, Huber G, Mühlhof A, Gembruch U. Prenatal medicine related to stress and depressive reactions of pregnant women and their partners. J Perinat Med. 2003; 31: 216–24.
  • Cederholm M, Haglund B, Axelsson O. Infant morbidity following amniocentesis and chorionic villus sampling for prenatal karyotyping. BJOG. 2005; 112: 394–402.
  • Lunkes A, Goldfarb LG, Platonov FA, Alexeev VP, Duenas-Barjas E, Gajdusek DC, etal. Autosomal dominant spinocerebellar ataxia (SCA) in a Siberian founder population: assignment to the SCA1 locus. Exp Neurol. 1994; 126: 310–12.
  • Goldfarb LG, Vasconcelos O, Platonov FA, Lunkes A, Kipnis V, Kononova S, etal. Unstable triplet repeat and phenotypic variability of spinocerebellar ataxia type 1. Ann Neurol. 1996; 4: 500–6.
  • Gorbunova VN, Saveleva-Vasileva EA, Krasilnikov VV. Diseases of neuromuscular system. Molecular neurology. 2000; St. Petersburg: Intermedica. [in Russian]..
  • Suhomyasova AL, Fedorova SA, Korotov MN, Maksimova NR, Alekseeva SP, Sidorova OG, etal. Myotonic dystrophy in the Republic of Sakha (Yakutia): population features and approaches to DNA testing. Yakut Med J. 2003; 2: 12–7 [in Russian].
  • Maksimova NR, Suhomjasova AL, Nogovicyna AN, Puzyrev VP. Ethnospecific hereditary pathology in the Republic of Sakha (Yakutia). Yakut Med J. 2009; 2: 15–9 [in Russian].
  • WHO. Proposed international guidelines on ethical issues in medical genetics and genetic services. 1997; Geneva: Report of World Health Organization meeting on ethical issues in medical genetics.
  • Material from Wikipedia – the free encyclopedia. Available from: http://ru.wikipedia.org/wiki/Yakutia..
  • Platonov FA, Illarioshkin SN, Kononova SK, Gogolev MP, Ivanova-Smolenskaja IA. Spinocerebellar ataxy type I in Yakutia: prevalence and clinical-genetics comparisons. Med Genet. 2004; 5: 242–8 [in Russian].
  • Mathew CC. The isolation of high molecular weight eukaryotic DNA. Methods Mol Biol. 1985; 2: 31–4.
  • Orr HT, Chang MY, Banfi S, Kwiatkowski TJ Jr , Servadio A, Beaudet AL, etal. Expansion of an unstable trinukleotide CAG repeat in spinoserebellar ataxia type 1. Nature Genet. 1993; 4: 221–6.
  • Brook JD, Mc Currach ME, Harley HG, Buckler AJ, Church D, Aburatani H, etal. Molecular basis of miotonic distrophy: expansion of a trinucleotide (CTG) repeat at the 3′end of a transcript encoding a protein kinase family member. Cell. 1992; 4: 799–808.
  • Rodrigues CSM, de Oliveira VZ, Camargo G, da Silva Osório CM, de Castilhos RM, Saraiva-Pereira ML, etal. Presymptomatic Testing for Neurogenetic Diseases in Brazil: Assessing Who Seeks and Who Follows through with Testing. J Genet Counsel. 2012; 21: 101–12.
  • Cruz MT, Velázquez PL, González ZY, Aguilera RR, Velázquez SM, Vázquez MY, etal. Couples at risk for spinocerebellar ataxia type 2: the Cuban prenatal diagnosis experience. J Community Genet. 2013; 4: 451–60.
  • Cruz MT, Velázquez PL, González ZY, Aguilera RR, Velázquez SM, Vázquez MY, etal. The Cuban program for predictive testing of SCA2: 11 years and 768 individuals to learn from. Clin Genet. 2013; 83: 518–24.
  • Stepanova SK, Zaharova VA, Tapuev EV, Suhomjasova AL, Maksimova NR. Pusirev VP, Tomski MI. Molecular and genetic methods of diagnostics of monogenic diseases in the Republic of Sakha (Yakutia). Genetic investigations of the population of Yakutia. Yakutsk: CIP NRB Sakha. 233–45.
  • Mariño TC, Armiñán RR, Cedeño HJ, Mesa JM, Zaldivar YG, Rodríguez RA, etal. Ethical dilemmas in genetic testing: examples from the Cuban program for predictive diagnosis of hereditary ataxias. J Genet Couns. 2011; 20: 241–8.
  • Catherine MG, Stephanie SA, Shannan DD, Jessica LS. Genetic counselors’ experiences with adolescent patients in prenatal genetic counseling. J Genet Couns. 2011; 20: 178–91.